nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0693	0.0743	CcSEcCtD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—focal segmental glomerulosclerosis	0.0679	1	CrCbGaD
Gadopentetate dimeglumine—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.0466	0.05	CcSEcCtD
Gadopentetate dimeglumine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.0349	0.0374	CcSEcCtD
Gadopentetate dimeglumine—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0322	0.0345	CcSEcCtD
Gadopentetate dimeglumine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0285	0.0306	CcSEcCtD
Gadopentetate dimeglumine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0252	0.0271	CcSEcCtD
Gadopentetate dimeglumine—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0215	0.0231	CcSEcCtD
Gadopentetate dimeglumine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0208	0.0223	CcSEcCtD
Gadopentetate dimeglumine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0191	0.0205	CcSEcCtD
Gadopentetate dimeglumine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.0194	CcSEcCtD
Gadopentetate dimeglumine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0172	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0172	CcSEcCtD
Gadopentetate dimeglumine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0171	CcSEcCtD
Gadopentetate dimeglumine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0163	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0162	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0149	0.0159	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0152	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0144	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0141	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0131	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0128	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0123	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0117	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0117	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0117	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0116	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0112	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00997	0.0107	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00982	0.0105	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00977	0.0105	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00975	0.0105	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00958	0.0103	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00927	0.00995	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00923	0.0099	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00902	0.00968	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00896	0.00962	CcSEcCtD
Gadopentetate dimeglumine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00892	0.00957	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.00953	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00935	CcSEcCtD
Gadopentetate dimeglumine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.0085	0.00911	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00848	0.0091	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00811	0.0087	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00796	0.00854	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00849	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00838	CcSEcCtD
Gadopentetate dimeglumine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00756	0.00811	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.0075	0.00805	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00747	0.00802	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.00791	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.00791	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00735	0.00788	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00785	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00721	0.00773	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.00764	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00707	0.00758	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.00743	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.00736	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.00733	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.00723	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.00691	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00634	0.00681	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0063	0.00676	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00628	0.00674	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00614	0.00659	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0061	0.00654	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00609	0.00654	CcSEcCtD
Gadopentetate dimeglumine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00648	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00648	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.00625	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.0062	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00602	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.00599	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.00599	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00521	0.00558	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00544	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.00536	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.00519	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00501	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00449	0.00482	CcSEcCtD
Gadopentetate dimeglumine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00478	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00478	CcSEcCtD
Gadopentetate dimeglumine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.00475	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0042	0.0045	CcSEcCtD
